These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16336329)

  • 1. Treatment of localized prostate cancer using high-intensity focused ultrasound.
    Uchida T; Ohkusa H; Nagata Y; Hyodo T; Satoh T; Irie A
    BJU Int; 2006 Jan; 97(1):56-61. PubMed ID: 16336329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study.
    Uchida T; Baba S; Irie A; Soh S; Masumori N; Tsukamoto T; Nakatsu H; Fujimoto H; Kakizoe T; Ueda T; Ichikawa T; Ohta N; Kitamura T; Sumitomo M; Hayakawa M; Aoyagi T; Tachibana M; Ikeda R; Suzuki K; Tsuru N; Suzuki K; Ozono S; Fujimoto K; Hirao Y; Monden K; Nasu Y; Kumon H; Nishi K; Ueda S; Koga H; Naitoh S
    Hinyokika Kiyo; 2005 Oct; 51(10):651-8. PubMed ID: 16285617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High-intensity focused ultrasound for localized prostate cancer].
    Uchida T
    Nihon Rinsho; 2005 Feb; 63(2):345-9. PubMed ID: 15714990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?
    Uchida T; Illing RO; Cathcart PJ; Emberton M
    BJU Int; 2006 Sep; 98(3):537-9. PubMed ID: 16925749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.
    Blana A; Brown SC; Chaussy C; Conti GN; Eastham JA; Ganzer R; Murat FJ; Pasticier G; Rebillard X; Rewcastle JC; Robertson CN; Thuroff S; Ward JF
    BJU Int; 2009 Oct; 104(8):1058-62. PubMed ID: 19388986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.
    Blana A; Walter B; Rogenhofer S; Wieland WF
    Urology; 2004 Feb; 63(2):297-300. PubMed ID: 14972475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.
    Ganzer R; Rogenhofer S; Walter B; Lunz JC; Schostak M; Wieland WF; Blana A
    Eur Urol; 2008 Mar; 53(3):547-53. PubMed ID: 17662520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
    Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
    Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.
    Inoue Y; Goto K; Hayashi T; Hayashi M
    Int J Urol; 2011 May; 18(5):358-62. PubMed ID: 21449970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.
    Pfeiffer D; Berger J; Gross AJ
    BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.
    Challacombe BJ; Murphy DG; Zakri R; Cahill DJ
    BJU Int; 2009 Jul; 104(2):200-4. PubMed ID: 19220245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience.
    Uchida T; Shoji S; Nakano M; Hongo S; Nitta M; Murota A; Nagata Y
    Int J Urol; 2009 Nov; 16(11):881-6. PubMed ID: 19863624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
    Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
    BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
    Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Whelan K; Shayegan B; Orovan WL
    BJU Int; 2012 Oct; 110(8):1142-8. PubMed ID: 22372721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
    Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
    BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].
    Poissonnier L; Gelet A; Chapelon JY; Bouvier R; Rouviere O; Pangaud C; Lyonnet D; Dubernard JM
    Prog Urol; 2003 Feb; 13(1):60-72. PubMed ID: 12703356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.
    Gelet A; Chapelon JY; Bouvier R; Pangaud C; Lasne Y
    J Urol; 1999 Jan; 161(1):156-62. PubMed ID: 10037389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.
    Ganzer R; Robertson CN; Ward JF; Brown SC; Conti GN; Murat FJ; Pasticier G; Rebillard X; Thuroff S; Wieland WF; Blana A
    BJU Int; 2011 Oct; 108(8 Pt 2):E196-201. PubMed ID: 21332907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.